日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adnectin-drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors

用于将细胞毒性有效载荷特异性递送至肿瘤的Adnectin-药物偶联物(靶向Glypican-3)

Daša Lipovšek ,Irvith Carvajal ,Alban J Allentoff ,Anthony Barros Jr ,John Brailsford ,Qiang Cong ,Pete Cotter ,Sanjeev Gangwar ,Cris Hollander ,Virginie Lafont ,Wai Leung Lau ,Wenying Li ,Miguel Moreta ,Steven O'Neil ,Jason Pinckney ,Michael J Smith ,Julie Su ,Christina Terragni ,Michael A Wallace ,Lifei Wang ,Martin Wright ,H Nicholas Marsh ,James W Bryson

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy

CT322 是一种 VEGFR-2 拮抗剂,在原位脑肿瘤模型中,无论单独使用还是与替莫唑胺和放射疗法联合使用,均显示出抗胶质瘤疗效。

Waters, J Dawn; Sanchez, Carlos; Sahin, Ayguen; Futalan, Diahnn; Gonda, David D; Scheer, Justin K; Akers, Johnny; Palanichamy, Kamalakannan; Waterman, Peter; Chakravarti, Arnab; Weissleder, Ralph; Morse, Brent; Marsh, Nick; Furfine, Eric; Chen, Clark C; Carvajal, Irvith; Carter, Bob S

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

纤连蛋白支架方法用于表皮生长因子受体和胰岛素样生长因子-I受体的双特异性抑制剂

Stuart L Emanuel, Linda J Engle, Ginger Chao, Rong-Rong Zhu, Carolyn Cao, Zheng Lin, Aaron P Yamniuk, Jennifer Hosbach, Jennifer Brown, Elizabeth Fitzpatrick, Jochem Gokemeijer, Paul Morin, Brent A Morse, Irvith M Carvajal, David Fabrizio, Martin C Wright, Ruchira Das Gupta, Michael Gosselin, Daniel

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2

CT-322 作为血管内皮生长因子受体 2 的 adnectin 抑制剂的抗肿瘤作用

Roni Mamluk, Irvith M Carvajal, Brent A Morse, Henry Wong, Janette Abramowitz, Sharon Aslanian, Ai-Ching Lim, Jochem Gokemeijer, Michael J Storek, Joonsoo Lee, Michael Gosselin, Martin C Wright, Ray T Camphausen, Jack Wang, Yan Chen, Kathy Miller, Kerry Sanders, Sarah Short, Jeff Sperinde, Gargi Pra